Parenterals

Mar 02, 2003
Pharmaceutical Technology
By Pharmaceutical Technology Editors
As parenteral drug delivery becomes more complex and sophisticated, excipients that can facilitate drug (or gene) delivery to specific therapeutic targets will be required. An overwhelming majority of these excipients are derived from natural sources.
Mar 02, 2003
Pharmaceutical Technology
The recently issued FDA concept paper about aseptic processing shows how the current guidelines could be expanded and makes recommendations for alternatives to traditional cleanroom installations such as isolator-equipped aseptic filling lines and blow?fill?seal equipment.
Mar 01, 2002
Pharmaceutical Technology
The development of a successful powder for injection formulation requires careful study of preformulation parameters, packaging and process parameters, and the elimination of particulate matter.
Mar 01, 2002
Pharmaceutical Technology
When FDA reviewed PDA's Technical Report No. 34 about isolator systems, significant differences of opinion between the organizations came to light.
Oct 02, 2001
Pharmaceutical Technology
Two types of hydrogels used in parenteral protein-delivery systems offer opportunities for achieving a variety of prolonged- and delayed-release patterns.
Jul 01, 2001
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Significant advances have shaped the past 25 years in the pharmaceutical industry, and the next 25 years will be no exception.
native1_300x100
lorem ipsum